Search This Blog

Tuesday, March 10, 2026

BTIG upgrades Alector to Buy with $6 price target

 


  • BTIG cites reduced post-trial uncertainty for Alector’s programs as a key reason for the upgrade.
  • Broker highlights renewed confidence in Alector Brain Carrier platform and GSK-partnered Alzheimer’s program.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)